[Psychotic disorders in Parkinson's disease and dementia with Lewy bodies].

Levin OS, Anikina MA, Shindriaeva NN, Zimniakova OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(6):82-8. Review. Russian. No abstract available.

Postural sway approaches center of mass stability limits in Parkinson's disease.

Menant JC, Latt MD, Menz HB, Fung VS, Lord SR.

Mov Disord. 2011 Mar;26(4):637-43. doi: 10.1002/mds.23547.

Does Tourette syndrome prevent tardive dyskinesia?

Müller-Vahl KR, Krueger D.

Mov Disord. 2011 Nov;26(13):2442-3. doi: 10.1002/mds.23894. No abstract available.

Botulinum toxin type A in children. New indication for limb spasticity.

[No authors listed]

Prescrire Int. 2011 Mar;20(114):68. No abstract available.

Costs of illness and care in Parkinson's disease: an evaluation in six countries.

von Campenhausen S, Winter Y, Rodrigues e Silva A, Sampaio C, Ruzicka E, Barone P, Poewe W, Guekht A, Mateus C, Pfeiffer KP, Berger K, Skoupa J, Bötzel K, Geiger-Gritsch S, Siebert U, Balzer-Geldsetze

Eur Neuropsychopharmacol. 2011 Feb;21(2):180-91. doi: 10.1016/j.euroneuro.2010.08.002.

Disease modification in Parkinson's disease.

Henchcliffe C, Severt WL.

Drugs Aging. 2011 Aug 1;28(8):605-15. doi: 10.2165/11591320-000000000-00000. Review.

Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours.

Friedman JH, Agarwal P, Alcalay R, Black KJ, Chou KL, Cote L, Dayalu P, Frank S, Hartlein J, Hauser RA, Lang AE, Marsh L, Marshall F, Moskowitz C, Ravina B, Riley D, Sanchez-Ramos J, Simon DK, Simuni

Int J Neurosci. 2011 Aug;121(8):472-6. doi: 10.3109/00207454.2011.578779.

Clinical, electrophysiological, and MRI findings in patients with cerebellar ataxia and a bilaterally pathological head-impulse test.

Kirchner H, Kremmyda O, Hüfner K, Stephan T, Zingler V, Brandt T, Jahn K, Strupp M.

Ann N Y Acad Sci. 2011 Sep;1233:127-38. doi: 10.1111/j.1749-6632.2011.06175.x.

New developments in CSF biomarkers for early detection and monitoring of Parkinson disease.

Yates D.

Nat Rev Neurol. 2011 Jan;7(1):1. doi: 10.1038/nrneurol.2010.184. No abstract available.

Restless legs syndrome as a possible predictor for psychiatric disorders in parents of children with ADHD.

Steinlechner S, Brüggemann N, Sobottka V, Benthien A, Behn B, Klein C, Schmid G, Lencer R.

Eur Arch Psychiatry Clin Neurosci. 2011 Jun;261(4):285-91. doi: 10.1007/s00406-010-0140-z.

Persistent dystonia following opioid withdrawal.

Aggarwal A, Kumar R, Sharma RC, Sharma DD.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):640. doi: 10.1016/j.pnpbp.2010.05.033. No abstract available.

Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.

Liu Z, Hamamichi S, Lee BD, Yang D, Ray A, Caldwell GA, Caldwell KA, Dawson TM, Smith WW, Dawson VL.

Hum Mol Genet. 2011 Oct 15;20(20):3933-42. doi: 10.1093/hmg/ddr312.

Milestones in Parkinson's disease--clinical and pathologic features.

Halliday G, Lees A, Stern M.

Mov Disord. 2011 May;26(6):1015-21. doi: 10.1002/mds.23669. Review.

Profile of altered brain iron acquisition in restless legs syndrome.

Connor JR, Ponnuru P, Wang XS, Patton SM, Allen RP, Earley CJ.

Brain. 2011 Apr;134(Pt 4):959-68. doi: 10.1093/brain/awr012.

Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's disease.

Lewis MM, Du G, Sen S, Kawaguchi A, Truong Y, Lee S, Mailman RB, Huang X.

Neuroscience. 2011 Mar 17;177:230-9. doi: 10.1016/j.neuroscience.2010.12.060.